NovAccess Global (XSNX) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free XSNX Stock Alerts $0.02 +0.01 (+80.72%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | americanbankingnews.comNovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Up 550.0% in AprilMay 7, 2024 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Advisory on Annual Meeting of ShareholdersApril 30, 2024 | finance.yahoo.comNovAccess Global Announces New License to Advance its Immunotherapy PlatformFebruary 7, 2024 | msn.comNovAccess Global Faces Default and Uncertain Rescue DealJanuary 2, 2024 | msn.comNovAccess Global jumps on announcing $10.7 million financingJanuary 2, 2024 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces $10.7 Million FinancingJanuary 2, 2024 | finance.yahoo.comNovAccess Global Announces $10.7 Million FinancingDecember 1, 2023 | finance.yahoo.comNovAccess Global Inc. to Present at the December 7th Virtual Investor SummitNovember 10, 2023 | finance.yahoo.comNovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory BoardNovember 2, 2023 | morningstar.comNovaccess Global Inc XSNXJuly 29, 2023 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy PlatformJuly 27, 2023 | finance.yahoo.comNovAccess Global Partners with BCN Biosciences to Expand Immunotherapy PlatformJuly 13, 2023 | finance.yahoo.comNovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness DayJuly 6, 2023 | finance.yahoo.comXSNX - NovAccess Global Inc.June 16, 2023 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine DivisionJune 16, 2023 | finance.yahoo.comNovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine DivisionJune 1, 2023 | finance.yahoo.comNovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare TherapiesMay 11, 2023 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine AdvancementsMay 11, 2023 | finance.yahoo.comNovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine AdvancementsMarch 15, 2023 | finanznachrichten.deNovAccess Global Inc.: Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardMarch 15, 2023 | finance.yahoo.comDr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardFebruary 16, 2023 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global to Present at World Orphan Drug CongressFebruary 16, 2023 | finance.yahoo.comNovAccess Global to Present at World Orphan Drug CongressFebruary 3, 2023 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual CongressFebruary 3, 2023 | finance.yahoo.comNovAccess Global Leadership to Present at World Brain Mapping Foundation Annual CongressJanuary 5, 2023 | finance.yahoo.comNovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics DivisionNovember 22, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient AdvocateNovember 22, 2022 | finance.yahoo.comNovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient AdvocateNovember 10, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory BoardNovember 10, 2022 | finance.yahoo.comNovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory BoardNovember 8, 2022 | finance.yahoo.comNovAccess Global Announces Virtual Annual Shareholders' MeetingOctober 26, 2022 | finance.yahoo.comNovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1October 20, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Fireside Chat with Board Member PerspectivesOctober 20, 2022 | finance.yahoo.comNovAccess Global Announces Fireside Chat with Board Member PerspectivesOctober 1, 2022 | finanznachrichten.deDarrow Associates, Inc.: NovAccess Global Announces Fireside Chat Series for the Investment CommunitySeptember 30, 2022 | seekingalpha.comXSNX NovAccess Global Inc.September 30, 2022 | seekingalpha.comXSNX NovAccess Global Inc.September 29, 2022 | finance.yahoo.comNovAccess Global Announces Fireside Chat Series for the Investment CommunitySeptember 23, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Effectiveness of Form S-1 Registration StatementSeptember 22, 2022 | finance.yahoo.comNovAccess Global Announces Effectiveness of Form S-1 Registration StatementSeptember 6, 2022 | reuters.comNovAccess Global IncAugust 10, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Uplisting to OTCQBAugust 10, 2022 | finance.yahoo.comNovAccess Global Announces Uplisting to OTCQBJuly 19, 2022 | finance.yahoo.comCORRECTION: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1July 19, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1July 19, 2022 | finance.yahoo.comNovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1June 16, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global CEO Dwain Irvin Featured on MoneyTVJune 14, 2022 | finance.yahoo.comNovAccess Global CEO Dwain Irvin Featured on MoneyTVJune 10, 2022 | finance.yahoo.comThis Week on MoneyTV with Donald Baillargeon, 6/10May 19, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global to Participate in LD Micro Invitational XII Conference Get NovAccess Global News Delivered to You Automatically Sign up to receive the latest news and ratings for XSNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. XSNX Media Mentions By Week XSNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XSNX News Sentiment▼1.380.42▲Average Medical News Sentiment XSNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XSNX Articles This Week▼10▲XSNX Articles Average Week Get NovAccess Global News Delivered to You Automatically Sign up to receive the latest news and ratings for XSNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATHX News Today ACUR News Today WCUI News Today AMPE News Today APVO News Today PRED News Today SXTC News Today ADTX News Today CMRA News Today BLPH News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:XSNX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceDems have chosen Biden replacement?Paradigm PressBill Gates is all about this tiny $2 stockTimothy SykesDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovAccess Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.